MicroWash Revenue and Competitors

Revolutionizing the sampling experience for the diagnosis of respiratory illnesses, MicroWash is the first nasal specimen collection device that delivers a comfortable, fast and high-quality sample. Surpassing the nasal swab on virtually all levels ― including comfort, accuracy, stability and accessibility ― MicroWash sets the new gold standard for respiratory infection nasal sampling in a post-pandemic world, equally preferred by patients and medical professionals alike. \n\nMicroWash is developed by University Medical Devices. Its mission is to provide cutting-edge and highly reliable specimen collection systems that improve the patient experience. The company’s leadership includes experts in neurology, emergency medicine, telehealth, urgent care, primary care, entrepreneurship and healthcare regulation with training at leading medical institutions.